Provectus Biopharmaceuticals Inc (PVCT)
0.1964
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Provectus Biopharmaceuticals Total Liabilities (Quarterly): 9.042M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.042M |
| September 30, 2023 | 9.209M |
| June 30, 2023 | 8.984M |
| March 31, 2023 | 8.722M |
| December 31, 2022 | 8.266M |
| September 30, 2022 | 8.909M |
| June 30, 2022 | 8.590M |
| March 31, 2022 | 7.825M |
| December 31, 2021 | 7.701M |
| September 30, 2021 | 3.549M |
| June 30, 2021 | 3.077M |
| March 31, 2021 | 32.39M |
| December 31, 2020 | 30.80M |
| September 30, 2020 | 30.06M |
| June 30, 2020 | 29.32M |
| March 31, 2020 | 26.69M |
| December 31, 2019 | 25.55M |
| September 30, 2019 | 24.15M |
| June 30, 2019 | 23.68M |
| March 31, 2019 | 22.50M |
| December 31, 2018 | 19.41M |
| September 30, 2018 | 17.71M |
| June 30, 2018 | 17.23M |
| March 31, 2018 | 15.55M |
| December 31, 2017 | 13.46M |
| Date | Value |
|---|---|
| September 30, 2017 | 11.16M |
| June 30, 2017 | 9.144M |
| March 31, 2017 | 5.431M |
| December 31, 2016 | 2.142M |
| September 30, 2016 | 5.376M |
| June 30, 2016 | 1.689M |
| March 31, 2016 | 1.835M |
| December 31, 2015 | 4.123M |
| September 30, 2015 | 2.075M |
| June 30, 2015 | 0.9954M |
| March 31, 2015 | 1.075M |
| December 31, 2014 | 0.9943M |
| September 30, 2014 | 2.108M |
| June 30, 2014 | 2.119M |
| March 31, 2014 | 6.271M |
| December 31, 2013 | 13.38M |
| September 30, 2013 | 4.057M |
| June 30, 2013 | 3.026M |
| March 31, 2013 | 3.816M |
| December 31, 2012 | 1.811M |
| September 30, 2012 | 3.587M |
| June 30, 2012 | 4.601M |
| March 31, 2012 | 4.257M |
| December 31, 2011 | 3.330M |
| September 30, 2011 | 4.502M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.077M
Minimum
Jun 2021
32.39M
Maximum
Mar 2021
16.13M
Average
9.042M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Insmed Inc | 1.662B |
| NeuroMetrix Inc | 1.333M |
| Intra-Cellular Therapies Inc | 136.87M |
| Rhythm Pharmaceuticals Inc | 162.99M |
| Amylyx Pharmaceuticals Inc | 84.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.449M |
| Shareholders Equity (Quarterly) | -7.593M |